Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse
NCT01087008
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
103
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
zoledronic acid
OTHER:
No treatment control
Sponsor
PETHEMA Foundation
Collaborators
[object Object]
[object Object]